Source:http://linkedlifedata.com/resource/pubmed/id/14013911
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1963-12-1
|
pubmed:keyword | |
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-4487
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
120(2)
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
281-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1962
|
pubmed:articleTitle |
[Clinical study of ethylbenzatropine (U.K. 738 or tropethydryline), a modifier of extrapyramidal syndromes due to neuroleptics].
|
pubmed:publicationType |
Journal Article
|